Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

MiNK Therapeutics Q4 EPS $(0.18)

MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.18) per share.
byBenzinga Newsdesk
March 18, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

MiNK Therapeutics (NASDAQ:INKT) reported quarterly losses of $(0.18) per share.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0